Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05464940 · ClinicalTrials.gov registry record · NA
Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction
A NA study, sponsored by Kansas City Heart Rhythm Research Foundation.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT05464940 is a NA study that has not yet begun recruiting, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 100 participants.
The verdict
NCT05464940, a NA study, has not yet begun recruiting, sponsored by Kansas City Heart Rhythm Research Foundation.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This "How caffeine Induces Atrial Tachyarrhythmias" trial will be a multi-center, randomized, double-blinded trial of intravenous caffeine versus placebo among patients undergoing pulmonary vein isolation procedures for Atrial Fibrillation(AF).
Interventions
- OTHER Intravenous caffeine
- OTHER Masked Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05464940
The ClinicalTrials.gov registry entry for NCT05464940 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kansas City Heart Rhythm Research Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous caffeine is the first listed.
NCT05464940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05464940 about?
NCT05464940 is a clinical study titled "Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction". This "How caffeine Induces Atrial Tachyarrhythmias" trial will be a multi-center, randomized, double-blinded trial of intravenous caffeine versus placebo among patients undergoing pulmonary vein isolation procedures for Atrial Fibrillation(AF).
What is the current status of trial NCT05464940?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09. Estimated completion is 2026-06.
What interventions are being tested in trial NCT05464940?
The interventions under investigation include: Intravenous caffeine (OTHER), Masked Placebo (OTHER).
Who is sponsoring clinical trial NCT05464940?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.